Free Trial

Kalpit Patel Analyst Performance

Analyst at Wolfe Research

Kalpit Patel is a stock analyst at Wolfe Research in the medical sector, covering 23 publicly traded companies. Over the past year, Kalpit Patel has issued 29 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Kalpit Patel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kalpit Patel's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
36 Last 4 Years
Buy Recommendations
60.00% 21 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy11.4%4 ratings
Buy48.6%17 ratings
Hold37.1%13 ratings
Sell2.9%1 ratings

Out of 35 total stock ratings issued by Kalpit Patel at Wolfe Research, the majority (48.6%) have been Buy recommendations, followed by 37.1% Hold, 11.4% Strong Buy, and 2.9% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
23 companies

Kalpit Patel, an analyst at Wolfe Research, currently covers 23 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
23 companies
100.0%

Kalpit Patel of Wolfe Research specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
18 companies
78.3%
MED - DRUGS
5 companies
21.7%

Kalpit Patel's Ratings History at Wolfe Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4/7/2026Downgrade$52.26Hold
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
3/27/2026Initiated Coverage$26.03$32.00Outperform
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/27/2026Initiated Coverage$14.12Peer Perform
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
3/27/2026Initiated Coverage$251.40Peer Perform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
3/27/2026Initiated Coverage$276.95$340.00Outperform
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/26/2026Upgrade$40.47Peer Perform
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/23/2026Boost Price Target$22.22$45.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
3/12/2026Reiterated Rating$109.43$110.00Outperform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
3/2/2026Reiterated Rating$236.07$260.00Outperform
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
1/12/2026Set Price Target$41.50$60.00
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
1/12/2026Reiterated Rating$41.57Outperform
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
12/31/2025Downgrade$36.05$30.00Underperform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/22/2025Boost Price Target$83.99$117.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
11/25/2025Lower Price Target$0.75$3.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
11/18/2025Initiated Coverage$7.98Peer Perform
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
11/18/2025Initiated Coverage$16.95Peer Perform
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
11/18/2025Initiated Coverage$47.25$75.00Outperform
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/18/2025Initiated Coverage$36.47$42.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/18/2025Initiated Coverage$69.14$75.00Outperform
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/18/2025Initiated Coverage$12.06Peer Perform
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
11/18/2025Initiated Coverage$28.72Peer Perform
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
11/18/2025Initiated Coverage$75.12Peer Perform
Celcuity, Inc. stock logo
CELC
Celcuity
11/18/2025Initiated Coverage$92.23$110.00Outperform
Arcellx, Inc. stock logo
ACLX
Arcellx
11/18/2025Initiated Coverage$90.34Peer Perform
Celcuity, Inc. stock logo
CELC
Celcuity
11/17/2025Upgrade$94.23Strong-Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/17/2025Upgrade$70.53Strong-Buy
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
11/17/2025Upgrade$47.00Strong-Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/17/2025Upgrade$39.69Strong-Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
6/3/2025Upgrade$43.13$60.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
5/2/2025Lower Price Target$9.19$14.00Neutral
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/20/2025Initiated Coverage$19.60$37.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
3/5/2025Boost Price Target$19.49$24.00Neutral
Geron Corporation stock logo
GERN
Geron
2/18/2025Lower Price Target$2.63$3.50Buy
Verastem, Inc. stock logo
VSTM
Verastem
1/31/2025Boost Price Target$6.39$9.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
1/30/2025Initiated Coverage$3.98$10.00Buy